中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)38411.7224069.6710824.4438643.8828210.48
营业收入(万元)38411.7224069.6710824.4438643.8828210.48
营业总成本(万元)51277.8333353.0515951.2078035.9954175.87
营业成本(万元)2702.451749.60714.922921.212144.93
净利润(万元)-7373.43-6625.12-3941.94-28169.09-20068.60
归属于母公司的净利润(万元)-9790.30-6653.61-3949.94-27858.27-20208.94
营业利润(万元)-11254.81-7943.60-4562.43-29778.24-21636.76
利润总额(万元)-11260.27-7949.34-4562.38-29908.45-21726.77
少数股东损益(万元)-1174.36-1099.16-513.14-1655.22-1220.67
基本每股收益(元)-0.37(元)-0.25(元)-0.15(元)-1.09(元)-0.80(元)
稀释每股收益(元)-0.37(元)-0.25(元)-0.15(元)-1.09(元)-0.80(元)
非经常性损益(万元)665.38583.52300.357016.24--
扣除非经常性损益后净利润(万元)-10455.68-7237.12-4250.29-34874.52-24328.07
总资产(万元)296714.79309966.30310474.80288720.68285906.19
总负债(万元)166434.19153129.71150403.60124236.98110962.77
归属于母公司股东权益合计(万元)130338.75156704.45159369.36163285.27173214.02
股东权益合计(万元)130280.60156836.60160071.20164483.70174943.42
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)309727.51335344.90335326.63335300.60337128.86
未分配利润(万元)-207681.47-204544.78-201841.11-197891.17-190241.84
经营活动产生的现金流量净额(万元)6664.7111255.318902.39-23275.06-22921.95
经营活动现金流入小计(万元)70286.4054016.2131002.4761187.0439778.67
经营活动现金流出小计(万元)63621.7042760.9022100.0984462.1162700.62
投资活动产生的现金流量净额(万元)845.533558.78-31590.156483.89-8245.08
投资活动现金流入小计(万元)101686.5879926.4511732.48126244.0166036.73
投资活动现金流出小计(万元)100841.0676367.6743322.63119760.1274281.81
筹资活动产生的现金流量净额(万元)-7812.564436.489461.21150936.58147972.04
筹资活动现金流入小计(万元)79800.0052800.0034900.00217617.28193727.28
筹资活动现金流出小计(万元)87612.5648363.5225438.7966680.7045755.24
期末现金及现金等价物余额(万元)207421.72227031.99194552.25207777.72190446.87
最后修改日期2024-10-292024-08-262024-04-202024-04-202023-10-28
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。